Stockscreener 앱 받기
36.80
4.31%
1.52
전일 마감가:
$35.28
열려 있는:
$35.35
하루 거래량:
537.81K
Relative Volume:
1.14
시가총액:
$1.02B
수익:
$3.25M
순이익/손실:
$-116.80M
주가수익비율:
-12.07
EPS:
-3.05
순현금흐름:
$-98.17M
1주 성능:
+6.77%
1개월 성능:
+25.17%
6개월 성능:
+322.02%
1년 성능:
+346.60%
1일 변동 폭
$35.27
$38.45
1주일 범위
$34.01
$38.45
52주 변동 폭
$5.6652
$42.39
Rapt Therapeutics Inc Stock (RAPT) Company Profile
명칭
Rapt Therapeutics Inc
전화
(650) 489-9000
주소
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
RAPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RAPT
Rapt Therapeutics Inc
|
36.80 | 977.64M | 3.25M | -116.80M | -98.17M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 개시 | Guggenheim | Buy |
| 2025-10-20 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-10-13 | 개시 | Barclays | Overweight |
| 2025-09-26 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-07-30 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2025-05-22 | 재개 | H.C. Wainwright | Buy |
| 2024-12-26 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-11-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-11-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-11-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-14 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-05-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-05-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-02-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-02-21 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-02-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-02-21 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-02-20 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-02-16 | 개시 | Evercore ISI | Outperform |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-09-14 | 개시 | Berenberg | Buy |
| 2023-08-09 | 개시 | Stifel | Buy |
| 2023-06-15 | 개시 | Barclays | Overweight |
| 2023-01-04 | 개시 | Guggenheim | Buy |
| 2022-12-01 | 개시 | Goldman | Buy |
| 2022-09-21 | 개시 | CapitalOne | Overweight |
| 2022-05-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-12-09 | 개시 | JP Morgan | Overweight |
| 2021-08-12 | 개시 | SVB Leerink | Outperform |
| 2021-06-21 | 개시 | Piper Sandler | Overweight |
| 2020-06-01 | 개시 | H.C. Wainwright | Buy |
| 2020-05-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-04-13 | 개시 | ROTH Capital | Buy |
| 2019-11-25 | 개시 | BMO Capital Markets | Outperform |
| 2019-11-25 | 개시 | UBS | Buy |
| 2019-11-25 | 개시 | Wells Fargo | Outperform |
모두보기
Rapt Therapeutics Inc 주식(RAPT)의 최신 뉴스
Rapt Therapeutics (NASDAQ:RAPT) Trading Up 4.9%Here's Why - MarketBeat
BVF Inc. IL Trims Holdings in Rapt Therapeutics $RAPT - MarketBeat
RAPT Therapeutics Announces Major Public Stock Offering - MSN
Rapt Therapeutics $RAPT Shares Sold by Redmile Group LLC - MarketBeat
Can RAPT Therapeutics Inc. (0RA) stock deliver strong annual returnsMarket Risk Summary & Growth Focused Investment Plans - Newser
Published on: 2025-12-04 13:14:54 - Newser
How RAPT Therapeutics Inc. (0RA) stock compares with tech leadersPortfolio Return Summary & Reliable Volume Spike Alerts - Newser
How robust is RAPT Therapeutics Inc. (0RA) stock financial positionVolume Spike & Risk Managed Trade Strategies - Newser
Does RAPT Therapeutics Inc (RAPT) offer a good opportunity for investors? - Setenews
Can RAPT Therapeutics Inc. (0RA0) stock sustain margin levels2025 Biggest Moves & Fast Moving Market Watchlists - Newser
What macro factors could drive RAPT Therapeutics Inc. (0RA0) stock higherRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Why RAPT Therapeutics Inc. (0RA) stock is trending on social mediaFed Meeting & Safe Capital Allocation Plans - Newser
How RAPT Therapeutics Inc. (0RA0) stock performs in easing cyclesRisk Management & Technical Pattern Based Buy Signals - Newser
Published on: 2025-12-02 05:12:24 - Newser
Can RAPT Therapeutics Inc. (0RA) stock ride next bull market cycle2025 Big Picture & Growth Oriented Trade Recommendations - Newser
RAPT Therapeutics announces planned departure of chief medical officer - Investing.com India
RAPT Therapeutics announces planned departure of chief medical officer By Investing.com - Investing.com Nigeria
RAPT Therapeutics Announces CMO Departure - TipRanks
RAPT Therapeutics Announces Departure of Chief Medical Officer - TradingView
Are Smart Investors Making the Right Decision? RAPT Therapeutics Inc (RAPT) - Setenews
RAPT Therapeutics, Inc.'s (NASDAQ:RAPT) Market Cap Touched US$830m Last Week, Benefiting Both Individual Investors Who Own 34% as Well as Institutions - 富途牛牛
While institutions invested in RAPT Therapeutics, Inc. (NASDAQ:RAPT) benefited from last week's 17% gain, individual investors stood to gain the most - simplywall.st
Form 8-KCurrent report - ADVFN
Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position - MSN
Foresite Capital Management VI LLC Decreases Stock Holdings in Rapt Therapeutics $RAPT - MarketBeat
RAPT Therapeutics Shares Surge on Institutional Confidence and Clinical Progress - AD HOC NEWS
Rapt Therapeutics (NASDAQ:RAPT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Rapt Therapeutics (NASDAQ:RAPT) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
RAPT rockets 180% on licensing deal, $150M private placement (update) - MSN
RAPT SEC FilingsRapt Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Will RAPT Therapeutics Inc. stock outperform Nasdaq index2025 Market Overview & Fast Moving Market Watchlists - newser.com
Why RAPT Therapeutics Inc. stock appeals to dividend seekersWeekly Trade Recap & Weekly Breakout Watchlists - newser.com
Why analysts remain bullish on RAPT Therapeutics Inc. stockTrade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com
Can RAPT Therapeutics Inc. stock deliver sustainable ROE2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
D pipelineJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
Is RAPT Therapeutics Inc. (0RA) stock a good hedge against inflationRisk Management & Daily Risk Controlled Trade Plans - newser.com
How strong is RAPT Therapeutics Inc. stock revenue growthWeekly Profit Recap & Verified Momentum Watchlists - newser.com
Is RAPT Therapeutics Inc. stock a buy before product launches2025 Biggest Moves & Long-Term Investment Growth Plans - newser.com
How supply shortages influence RAPT Therapeutics Inc. (0RA0) stockJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
How RAPT Therapeutics Inc. (0RA0) stock stacks up against competitorsJuly 2025 Selloffs & Risk Controlled Daily Plans - newser.com
Published on: 2025-11-19 17:30:40 - newser.com
Rapt Therapeutics Inc (RAPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):